To identify statistically significant differences in the risk of (recurrent) stroke, myocardial infarction (MI), or mortality between groups with different levels of fasting total-cholesterol (TC) and triglyceride (TG).
INTRODUCTION
A linear relationship between increasing total-cholesterol (TC) levels and increasing risk of lethal myocardial infarction (MI) has been demonstrated in men from Northern Europe and the USA [1] [2] [3] [4] [5] [6] [7] [8] [9] , but this relationship is weaker in women [1, 6, [8] [9] or no correlation has been shown [10, 11] .
Several studies have reported both relationship and lack of an association between increasing TC levels and increasing risk of ischemic stroke and stroke mortality [3, 4, 8, 12] . Some studies have suggested a correlation between increasing TC levels and increasing total mortality in those aged < 50 years [8, 13, 14] . Other studies have reported a flat relationship in women between TC levels and total mortality but a U-like relationship in men due to an increased risk of for example cancer DOI: https://doi.org/10.30654/MJN.10014 2 at low TC levels [6] .
Triglycerides (TG) have been reported to be a risk factor for MI [9, 10] , MI and all-cause mortality in both men and women [15] , compared to other studies where TG is reported as a risk factor only in women for MI [11, 16] and all-cause mortality [8, 11, 16] .
The introduction of statins [17] markedly changed lipidlowering treatment because of their positive effects on lowering the risk of stroke [5, [18] [19] [20] , MI, and major vascular events in both sexes [5, [19] [20] [21] , but the positive effect on survival differs between studies [5, 18, 19, [21] [22] [23] .
The purpose with this retrospective study was to determine if there were statistically significant differences in the risk of (recurrent) stroke, MI, or mortality between the sexes and between groups with different levels of TC and TG.
MATERIAL AND METHODS
This study included patients with TIA/stroke hospitalized in 1986 at the Stroke unit or Department of Neurology and who had a fasting lipid analysis performed at admission. All patients were followed up until February 2011 [24] . TIA was defined as an acute onset of focal neurological symptom(s) and sign(s) or retinal that had been transient within 24 hours. 
RESULTS

Baseline characteristics
A total of 224 patients, which included 96 women, were classified into three different subgroups of TC and were compared to patients without assessed fasting TC values.
The patients' baseline characteristics are shown in Table 1 .
Angiography and/or doppler of the symptomatic carotid artery showed > 50% stenosis/occlusion in 2/7 (29%) of men and 1/2 and 42 %, (ns). Analysis of three TG levels and corresponding frequency of MI was: men 45%; 38% and 59% (ns), respectively; women 28%; 47% and 42% (ns), respectively. Analysis of TC levels 5-5.4 mmol/L, 5.5-5.9 mmol/L, 6-6.4 mmol/L, showed the frequency of MI during life was: men 39%; 35%, 56%, respectively; women, 17%, 41%, 23%, respectively. classified into 6 subgroups for all-cause mortality and vascular causes of death: ≤4.9 mmol/L, 5-5.9 mmol/L, 6-6.9 mmol/L,7-7.9 mmol/L, 8-8.9 mmol/L, and ≥9 mmol/L. All-cause mortality in women was 85%, 83%, 69%, 88%, 83%, and 80%, respectively, and in men was 91%, 87%, 97%, 83%, 88%, and 83%, respectively. Vascular cause of death (not index stroke) in women was 69%, 59%, 46% , 65% , 67%, and 60%, respectively, and in men was 44%, 50%, 87%, 83%; 63% and 83%, respectively. year) in women by 4, 5.5, and 6.8, respectively, and in men by 6.3, 6.6, and 5.9, respectively. The risk of vascular death (not index stroke) relative to the 3 TG levels was higher in men than women: 63% vs. 57%, 69% vs. 58%, 67% vs. 58%, respectively. subgroups of TC and TG in combination is given in Figure 1 . [8] . Another study demonstrated that low TC value was a risk factor for increased risk of death from cancer of the liver and pancreas in men, hepatic cirrhosis, and suicide [3] . Others [6, 14] have also assessed similar results.
No significant correlations were observed between the different TG levels and risk of stroke and MI separately, but between sexes regarding stroke: TG <1.6 mmol/L, P=0.011. The women with a TG level > 2.2 mmol/L had a higher risk of death than those <1.6 mmol/L, P=0.017. At a TG level < 1.6 mmol/L, women had better survival than men, P=0.004. Men had a higher risk of mortality at the lowest TG levels and women had a higher risk of mortality at TG> 2.2 mmol/L. These results are consistent with other published Swedish studies which have reported the effect of cholesterol and triglycerides levels in men or women with ischaemic heart disease [10, 11] .
The annual risk of stroke and MI was lower with lipid-lowering treatment (usually statins) compared to no treatment after 12 years follow-up in this study, which supports lipid-lowering treatment as a method to reduce the risk of stroke and MI. In total, however, this long-term observational study is mainly a study without lipid-lowering treatment.
This study supports the assumption that men with TC in the range of 5-6.4 would have greater benefit from lipid-lowering treatment compared to women. The treatment goal for men should therefore be TC <5 mmol/L, but in men with high TC levels and with a history of malignant cancer, TC range 5-6.4 mmol/L due to findings of increased annual risk of MI events at a lower TC level. The TC range of 5-6.4 mmol/L seems to be best for most women due to the U-shaped risk in women regarding the risk of MI and CVD relative to the TC level.
High fasting TG level which was shown to be a significant risk factor for CVD may require lifestyle changes with good eating habits, increased exercise, possible weight loss, review of alcohol habits, investigation of other reasons and determination of non-high-density-lipoprotein cholesterol (non-HDL-C) before lipid-lowering treatment becomes relevant.
As in the previous study that did not include TC/TG levels in Cox regression analysis to assess predictors of death [24] , this study also supports treatment of high systolic blood pressure, fasting blood glucose ≥6.1 mmol/L or history of diabetes, both in primary and secondary prevention, and administration of antithrombotic/antiplatelet therapy as secondary prophylaxis with no contraindications.
CONCLUSIONS
TC and TG levels measured after admission effect men and women differently regarding the risk for risk for stroke, MI, CVD and survival. These differences in outcomes between the sexes might support the fact that the indication for lipidlowering treatment is partly dependent on sex.
